BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37983868)

  • 1. Stereotactic Radiosurgery and Radiotherapy for Vestibular Schwannoma in NF2-Related Schwannomatosis.
    Shrivastava M; Emmanouil B; Mathew R; Halliday D; Parry A; Halliday J; Mackeith S
    Laryngoscope; 2024 May; 134(5):2364-2371. PubMed ID: 37983868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic radiosurgery for vestibular schwannomas: average 10-year follow-up results focusing on long-term hearing preservation.
    Watanabe S; Yamamoto M; Kawabe T; Koiso T; Yamamoto T; Matsumura A; Kasuya H
    J Neurosurg; 2016 Dec; 125(Suppl 1):64-72. PubMed ID: 27903183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma Knife radiosurgery for treatment of growing vestibular schwannomas in patients with neurofibromatosis Type 2: a matched cohort study with sporadic vestibular schwannomas.
    Kruyt IJ; Verheul JB; Hanssens PEJ; Kunst HPM
    J Neurosurg; 2018 Jan; 128(1):49-59. PubMed ID: 28128697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated Stereotactic Radiotherapy Compared to Stereotactic Radiosurgery for Vestibular Schwannoma in Patients with Type 2 Neurofibromatosis.
    Mauro GP; Da Róz LM; Gico VC; Weltman E; César de Souza E; Figueiredo EG; Teixeira MJ
    World Neurosurg; 2023 Nov; 179():e416-e420. PubMed ID: 37657590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing Preservation for Vestibular Schwannomas Treated with Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy.
    Udawatta M; Kwan I; Preet K; Nguyen T; Ong V; Sheppard JP; Duong C; Romiyo P; Lee P; Tenn S; Kaprealian T; Gopen Q; Yang I
    World Neurosurg; 2019 Sep; 129():e303-e310. PubMed ID: 31132496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcomes of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy using the CyberKnife
    Puataweepong P; Dhanachai M; Swangsilpa T; Sitathanee C; Ruangkanchanasetr R; Hansasuta A; Pairat K
    Asia Pac J Clin Oncol; 2022 Oct; 18(5):e247-e254. PubMed ID: 34310064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Hearing Preservation Outcomes in Patients With Sporadic Vestibular Schwannomas.
    Carlson ML; Vivas EX; McCracken DJ; Sweeney AD; Neff BA; Shepard NT; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E35-E39. PubMed ID: 29309683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review.
    Persson O; Bartek J; Shalom NB; Wangerid T; Jakola AS; Förander P
    Acta Neurochir (Wien); 2017 Jun; 159(6):1013-1021. PubMed ID: 28409393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities.
    Lo A; Ayre G; Ma R; Hsu F; Akagami R; McKenzie M; Valev B; Gete E; Vallieres I; Nichol A
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):443-451. PubMed ID: 29066124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased cochlear radiation dose predicts delayed hearing loss following both stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannoma.
    Patel KS; Ng E; Kaur T; Miao T; Kaprealian T; Lee P; Pouratian N; Selch MT; De Salles AAF; Gopen Q; Tenn S; Yang I
    J Neurooncol; 2019 Nov; 145(2):329-337. PubMed ID: 31552587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Radiosurgery for Vestibular Schwannoma in Neurofibromatosis Type 2: An International Multicenter Case Series of Response and Malignant Transformation Risk.
    Bin-Alamer O; Faramand A; Alarifi NA; Wei Z; Mallela AN; Lu VM; Nabeel AM; Reda WA; Tawadros SR; Abdelkarim K; El-Shehaby AMN; Emad RM; Peker S; Samanci Y; Lee CC; Yang HC; Delabar V; Mathieu D; Tripathi M; Kearns KN; Bunevicius A; Sheehan JP; Chytka T; Liscak R; Moreno NM; Álvarez RM; Grills IS; Parzen JS; Cifarelli CP; Rehman AA; Speckter H; Niranjan A; Lunsford LD; Abou-Al-Shaar H
    Neurosurgery; 2023 May; 92(5):934-944. PubMed ID: 36861994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single institution experience treating 104 vestibular schwannomas with fractionated stereotactic radiation therapy or stereotactic radiosurgery.
    Anderson BM; Khuntia D; Bentzen SM; Geye HM; Hayes LL; Kuo JS; Baskaya MK; Badie B; Basavatia A; Pyle GM; Tomé WA; Mehta MP
    J Neurooncol; 2014 Jan; 116(1):187-93. PubMed ID: 24142200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up studies of Gamma Knife surgery for patients with neurofibromatosis Type 2.
    Sun S; Liu A
    J Neurosurg; 2014 Dec; 121 Suppl():143-9. PubMed ID: 25434947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linac-based stereotactic radiosurgery and fractionated stereotactic radiotherapy for vestibular schwannomas: comparative observations of 139 patients treated at a single institution.
    Puataweepong P; Dhanachai M; Dangprasert S; Narkwong L; Sitathanee C; Sawangsilpa T; Janwityanujit T; Yongvithisatid P
    J Radiat Res; 2014 Mar; 55(2):351-8. PubMed ID: 24142966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trigeminal neuropathy in vestibular schwannoma: a treatment algorithm to avoid long-term morbidity.
    Galloway L; Palaniappan N; Shone G; Hayhurst C
    Acta Neurochir (Wien); 2018 Apr; 160(4):681-688. PubMed ID: 29344779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisession stereotactic radiosurgery for large vestibular schwannomas.
    Casentini L; Fornezza U; Perini Z; Perissinotto E; Colombo F
    J Neurosurg; 2015 Apr; 122(4):818-24. PubMed ID: 25594321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on Surgical Resection for the Treatment of Patients With Vestibular Schwannomas.
    Hadjipanayis CG; Carlson ML; Link MJ; Rayan TA; Parish J; Atkins T; Asher AL; Dunn IF; Corrales CE; Van Gompel JJ; Sughrue M; Olson JJ
    Neurosurgery; 2018 Feb; 82(2):E40-E43. PubMed ID: 29309632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of hearing loss after LINAC-based stereotactic radiotherapy for vestibular schwannoma is associated with cochlear dose, not with pre-treatment hearing level.
    van Linge A; van Os R; Hoekstra N; Heijmen B; Stienstra L; Dallenga A; Wolbers J; Mendez Romero A
    Radiat Oncol; 2018 Dec; 13(1):253. PubMed ID: 30583739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Cohort Study of Longitudinal Audiologic Assessment in Single and Fractionated Stereotactic Radiosurgery for Vestibular Schwannoma.
    Khattab MH; Sherry AD; Whitaker R; Wharton DM; Weaver KD; Chambless LB; Cmelak AJ; Attia A
    Neurosurgery; 2019 Dec; 85(6):E1078-E1083. PubMed ID: 31215628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Useful hearing preservation is improved in vestibular schwannoma patients who undergo stereotactic radiosurgery before further hearing deterioration ensues.
    Ogino A; Long H; Johnson S; Faramand A; Niranjan A; Flickinger JC; Lunsford LD; Kano H
    J Neurooncol; 2021 May; 152(3):559-566. PubMed ID: 33733428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.